rasagiline tablet

1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson’s disease

alvogen, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] fatigue` `[4] off label use` `[5] pain` `[6] dyspnoea` `[7] headache` `[8] diarrhoea` `[9] fall` `[10] pneumonia`

4 years ago

ROUND WHITE R2

16 HOW SUPPLIED/STORAGE AND HANDLING

RASAGILINE Tablets 0.5 mg: white to off-white, round, flat, beveled tablets, debossed with “R1” on one side and plain on the other side. Supplied as bottles of 30 tablets (NDC 47781-683-30)

RASAGILINE Tablets 1 mg: white to off-white, round, flat, beveled tablets, debossed with “R2” on one side and plain on the other side. Supplied as bottles of 30 tablets (NDC 47781-690-30) Storage: Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

More pills like ROUND R2

Related Pills

rasagiline tablet

alvogen, inc.

risperidone 2 mg tablet

amneal pharmaceuticals ny llc

Diltiazem Hydrochloride 24 HR Diltiazem Hydrochloride 240 MG Extended Release Oral Capsule

Rebel Distributors Corp

Gabapentin gabapentin 300 MG Oral Capsule

Actavis Pharma, Inc.

ritalin la methylphenidate hydrochloride capsule extended release

novartis pharmaceuticals corporation

risperidone tablet

torrent pharmaceuticals limited

Rosuvastatin calcium 20 MG Oral Tablet

novadoz pharmaceuticals llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site